To study the mechanism of the diabetogenic action of ethanol, ethanol (0.75 g/kg over 30 min) and then glucose (0.5 g/kg over 5 min) were infused intravenously into six normal males. During the 4-h study, 21.8±2.1 g of ethanol was metabolized and oxidized to CO2 and H20. Ethanol decreased total body fat oxidation by 79% and protein oxidation by 39%, and almost completely abolished the 249% rise in carbohydrate (CHO) oxidation seen in controls after glucose infusion. Ethanol decreased the basal rate of glucose appearance (GR.) by 30% and the basal rate of glucose disappearance (GR,) by 38%, potentiated glucose-stimulated insulin release by 54%, and had no effect on glucose tolerance. In hyperinsulinemic-euglycemic clamp studies, ethanol caused a 36% decrease in glucose disposal. We conclude that ethanol was a preferred fuel preventing fat, and to lesser degrees, CHO and protein, from being oxidized. It also caused acute insulin resistance which was compensated for by hypersecretion of insulin.
Introduction
The effects of ethanol on carbohydrate (CHO)' metabolism are complex. When given to individuals whose glycogen stores have been depleted by fasting, ethanol can lead to severe hypoglycemia primarily by reducing hepatic glucose production through inhibition of gluconeogenesis (1, 2) . The effects of ethanol in fed individuals are less well understood. In numerous studies, using many different experimental protocols, ethanol pretreatment has been associated with diminished (3), improved (4, 5) , or unchanged (6, 7) glucose tolerance. Moreover, several patients have been reported in whom ethanol abuse led to overt diabetes mellitus which disappeared with abstinence from alcohol (8, 9) . The mechanism for this diabetogenic effect of ethanol remains unknown. Because of the existing confusion in this area and the potential clinical importance of the problem, we have investigated, in normal male subjects, the acute effects of ethanol on the metabolism of an intravenous glucose load. To this end, we have measured total body CHO, fat, and protein oxidation by indirect calorimetry, glucose appearance and disappearance from the extracellular space by glucose dilution analysis and glucose disposal under hyperinsulinemic-euglycemic conditions with the clamp technique.
Methods

Subjects
Fourteen healthy male medical students and hospital employees, age 23.4±0.8 yr (range 21-29 yr), body weight 81.0±3.0 kg (range 70.5-108.0 kg), and relative ideal body weight 105±2% (range 96-120%), participated in four study protocols. None had a family history of diabetes or alcoholism, admitted to drinking more than six drinks per week, or had consumed ethanol during the 72 h prior to any study and none were taking any medications. Informed written consent was obtained from all after explanation of the nature, purpose, and potential risks ofeach study. All study protocols were approved by the Human Research Committee of Temple University. The studies were performed in the General Clinical Research Center of Temple University Hospital and began between 7 and 8 a.m. after an overnight fast. The subjects were studied while reclining in hospital beds.
Study design
Four study protocols were used. Protocol 1: glucose infusion studies. Six subjects were studied twice in random order with and without ethanol. A minimum of 7-10 d was allowed between ethanol and control (saline) studies. Catheters were placed in peripheral veins in each arm. One line was used to infuse ethanol, saline, glucose, and radiolabeled substances. A second line, in the contralateral arm, was used for blood sampling and was kept patent by a slow infusion of normal saline. Ethanol and control studies were identical except for the substitution of normal saline for ethanol in control studies. After a 2-h baseline period (-120 to 0 min), alcohol (0.75 g/kg, USP, Abbott Laboratories, N. Chicago, IL) diluted in normal saline to make a 12.5% solution, was infused intravenously for 30 min (0-30 min). Glucose (0.5 g/kg) was infused intravenously for 5 min starting at 60 min. Venous blood was collected for determination of plasma glucose concentration every 10 min for the next hour and at 30-min intervals thereafter. Venous blood samples for determination of insulin, glucagon, free fatty acids, norepinephrine, epinephrine, ethanol, acetate, and acetaldehyde concentrations were obtained at 15-or 30 -min intervals for 4 h.
Ethanol was determined in aliquots of urine collected at -30-min intervals. For estimation ofbreath ethanol excretion by gas chromatography, expired air was collected in glass flasks at 30-min intervals after ethanol administration as previously described for acetone (10 second ethanol load of 0.5 g/kg was administered over 30 min followed by the same maintenance infusion (100 mg/kg per h) until the completion of the study. Venous samples for determination of ethanol, insulin, glucagon, and free fatty acids were obtained at 0, 30, and every 15 min thereafter until completion ofthe studies. To determine whether it was necessary to obtain arterialized blood during euglycemic-hyperinsulinemic clamps we determined, in three separate studies, arteriovenous (a-v) glucose concentration differences during the basal and hyperinsulinemic phases of the clamps in blood collected simultaneously from a radial artery and a superficial antecubital vein. During euglycemic-euinsulinemic (insulin 9 ,U/ml) conditions glucose a-v differences were +3, +7, and 0 mg/dl, respectively (mean 3.3 mg/dl). During euglycemic-hyperinsulinemic (insulin 80 ,U/ml) conditions glucose a-v differences were +6, +5, and +6 mg/dl, respectively (mean 5.6 mg/dl). Thus, a-v glucose differences were small during euinsulinemic and hyperinsulinemic euglycemia, which eliminated the need for collection of arterialized blood.
In vitro insulin binding
In vitro insulin binding was determined with primary cultures of rat hepatocytes prepared as previously described (16) . Monolayers of hepatocytes (-2 X 106 cells/flask) were preincubated in the absence or presence of ethanol in five different concentrations ranging from 100 to 1,000 mg/dl and with normal human serum (diluted 1:25) in MEM (final volume: 2.5 ml) at 37°C for 120 min. After preincubation, the medium was aspirated and the cells washed twice with ice-cold KrebsRinger bicarbonate buffer (pH 7.4). 25I-insulin binding was then determined as described (16) . Interference of ethanol with '25l-insulin binding was assessed with cells not pre-incubated with ethanol but exposed to ethanol during the insulin binding assay.
Analytic procedures
Plasma glucose was measured with a Beckman Instruments glucose analyzer. Plasma insulin (17) and glucagon (18) were determined by radioimmunoassay. Plasma free fatty acids were measured according to Lorch and Gey (19) after extraction according to Dole and Meinertz (20) . Plasma catecholamines were measured radioenzymatically (21) . Plasma and urine ethanol were determined with a kit (Sigma Chemical Co., St. Louis, MO) as were blood acetate and acetaldehyde (Boehringer Mannheim, Elkhart, IN). For the determination ofacetate and acetaldehyde (22) by enzymatic analysis, blood samples were immediately deproteinized and neutralized with perchloric acid/KOH and metaphosphoric acid/KOH, respectively, prior to assay.
Statistical analysis and calculations
All data are expressed as the mean±SEM. Statistical significance was assessed using MANOVA or Student's two-tailed paired t test when appropriate.
Ethanol disappearance and metabolism
The rate of ethanol disappearance from the blood was calculated using the following formula: Ethanol disappearance = B X P X 'y, where B = change in plasma ethanol concentration (mg/dl) obtained from the linear part of the plasma ethanol curve; P = body weight (kg) X 1.06 to correct for differences in density between blood and water; and 'y = coefficient of distribution for ethanol (and acetate) (23).
Ethanol metabolism was determined according to the following formula: Ethanol metabolized = ethanol disappeared from blood -ethanol excreted in urine and breath -ethanol present in plasma as acetate.
CHO, fat, and protein oxidation rates
Respiratory quotients (RQ) were obtained from the computerized analysis of respiratory gas exchange by the Metabolic Measurement Cart as described (24) . Based on our finding (['4C]ethanol oxidation studies, protocol 3) of complete oxidation of ethanol to CO2 and H20 during the 4-h study, these respiratory exchange data were corrected by subtracting the volumes of 02 consumed and CO2 produced during ethanol oxidation (complete oxidation of I mol ofethanol consumes 3 mol of 02 and produces 2 mol of CO2). Protein oxidation rates were calculated from urinary nitrogen excretion and used to determine non-protein RQs. The ethanol-corrected non-protein RQs were then used to calculate CHO and fat oxidation rates as described previously (24) .
Results
Effect ofethanol on glucose tolerance and insulin (Fig. 1) . Infusion of ethanol (0.75 g/kg over ethanol concentrations declined at a constant rate and reached 48±5 mg/dl at 240 min. These ethanol concentrations resulted in mild motor hyperactivity at the beginning and sleepiness during the later phases of the study in most subjects.
Blood acetate concentrations rose quickly after ethanol infusion to a peak of 4.7±0.4 mg/dl and remained elevated at about this level throughout the study. Acetaldehyde (not shown) was undetectable (< 0.008 mg/ml) in peripheral venous blood in all subjects at the time of peak ethanol concentration (30 min) and remained undetectable in five of six subjects at the end of the study in accordance with previously reported data (25).
Ethanol infusion had no significant effects on plasma glucose concentrations nor the rate ofglucose disappearance from plasma after intravenous glucose.
Ethanol had no effect on basal, but significantly enhanced glucose-stimulated insulin concentrations between 70 and 105 min. For instance, at 70 min, insulin concentrations with ethanol were 86±14 uU/ml compared with 56±8 uU/ml with saline (P < 0.05). The total 3-h glucose-stimulated insulin response (area under the curve between 60 and 240 min) was 54% greater with ethanol than with saline (7,153±1,710 vs.
4,650±905,uU/ml -min-', P < 0.025).
Plasma FFA concentrations were not significantly different in ethanol vs. control studies except during the last hour in which plasma FFA concentrations in the ethanol study remained suppressed, while those in the control study started to rise towards baseline levels. After glucose, FFA concentrations decreased precipitously from 480±121 and 470±61 ,eq/liter at 60 min to 69±16 and 46±17,ueq/liter at 120 min in control and ethanol studies, respectively (P < 0.01).
Counterregulatory hormones (Fig. 2) . Except for transient and isolated increases in norepinephrine at 75 min and epinephrine at 30 min, ethanol had no significant effects on plasma norepinephrine, epinephrine, or glucagon concentrations.
Oxidation ofCHO, fat, and protein (Fig. 3) . To assess possible effects of ethanol on intracellular substrate utilization, we measured CHO, fat, and protein oxidation rates by indirect calorimetry. The use ofthis method in the presence ofethanol, was validated in the ['4C]ethanol oxidation studies (vide infra).
Ethanol infusions had no significant effect on mean resting metabolic rates (944±6 and 931±1 cal/min per 1.73 m2 in ethanol and control studies, respectively).
Basal (-30 to 0 min) rates of CHO oxidation were 40±5 and 46±5 mg/min per 1.73 m2 in control and ethanol studies, respectively. Saline or ethanol infusions had no statistically significant effects on CHO oxidation. Glucose infusion in controls caused a 249% increase in CHO oxidation at 120 min (from 47± 12 to 117± 11 mg/min per 1.73 i2, p < 0.025). This glucose-stimulated increase was virtually abolished by ethanol and the total integrated above basal 3-h CHO oxidation was diminished by 80% (from 7.1±0.2 to 1.4±0.2 g per 1.73 m2, P < 0.05).
Basal rates of fat oxidation in control and ethanol studies were similar (69±8 and 72±5 mg/min per 1.73 m2). Ethanol infusion suppressed fat oxidation by 87% from 72±3 (at 0 min) to 9±3 mg/min per 1.73 m2 (at 60 min) (P < 0.001). Saline had no effect. After glucose infusion, fat oxidation decreased in controls in a reciprocal fashion to the increase in CHO oxidation (from 60± 10 to 32±6 mg/min per 1.73 m2) and then rose toward basal values. In ethanol studies after glucose infusion, ethanol in four of six subjects. In the two subjects whose bicarbonate pool was primed with NaH'4C03, '4C02 sp act were stable throughout the studies (6.3 and 3.9 nCi/mmol, respectively). Of Glucose turnover (Fig. 5, protocol 2) . Basal rates (0 min) of glucose appearance (GR.) were similar in ethanol and control studies. Infusion of ethanol caused a 30% decrease in GRa (from 2.4±0.2 to 1.7±0.1 mg/kg per min, P < 0.05) while saline had no effect. Because of the reduced basal GR., peak total (endogenous + exogenous) GR. at 90 min was also less in ethanol than in control studies (8.7±0.7 vs. 9.7±0.6 mg/kg per min, P < 0.005) and remained lower than in controls until the end of the study. The total integrated 3-h glucose appearance (60-240 min) was 24% less in ethanol than in control studies (515±25 vs. 677±31 mg/kg, P < 0.005). Basal rates of glucose disappearance (GRd) were similar in ethanol and control studies. Ethanol infusion suppressed GRd by 38% (from 2.20±0.4 to 1.4±0.2 mg/kg per min, P < 0.05) while saline had no effect. GRd was lower in ethanol than in saline experiments during all except one time period (120 min). The total integrated 3 h (60-240 min) glucose disappearance in the presence of ethanol was 21% less compared with controls (533±25 vs. 677±30 mg/kg, P < 0.005).
Effect of ethanol on glucose disposal (Fig. 6 ). Intravenous administration of a glucose load after ethanol infusion was associated with increased release of insulin but unchanged glucose tolerance (Fig. 1) , suggesting acute onset of insulin resistance. To study the ethanol-induced insulin resistance in more detail, we performed hyperinsulinemic-euglycemic hour of the study. There was no difference in the effect of the two ethanol concentrations on glucose disposal nor on any of the other parameters measured. The most likely reason for this was that ethanol oxidation was maximal at the low ethanol concentration (-56 mg/dl) because of the low Km of hepatic alcohol dehydrogenase (about 5 mg/dl). It also suggested that the observed effects were not caused by ethanol itself, but probably by one or more of its metabolites. Plasma glucose concentrations were maintained at 80±0.4 mg/dl and 79±0.4 mg/dl in ethanol and control studies, respectively. Plasma insulin concentrations rose from 9±1 to 80±2
,qU/ml in ethanol studies and from 8±1 to 81 ±+1 ,U/ml in control studies as result of the insulin infusion (1 mU/kg per min). At these insulin concentrations, hepatic glucose production is known to be completely suppressed and the rate of glucose infused (by the Biostator) to maintain euglycemia equals the rate of glucose disposal, i.e., the amount of glucose leaving the extracellular glucose space (26) . Since ethanol inhibited GRa, it seemed reasonable to assume that hepatic glucose production remained completely suppressed during ethanol plus insulin infusions. Glucose disposal rates prior to ethanol were not significantly different in ethanol or control studies (5.8±0.8 vs. 5.9±0.9 mg/kg per min at 120 min). In response to continued hyperinsulinemia, glucose disposal rates in the control studies rose from 5.8±0.8 to a peak of 8.8±1.1 mg/kg per min and remained at about this level. This increase was completely abolished by ethanol which kept glucose disposal rates at about 5.7±1.1 mg/kg per min throughout. Integrated 3-h (120-300 min) glucose disposal with ethanol was 947±132 mg/kg vs. 1,485+154 mg/kg with saline (-36%, P < 0.02). Ethanol had no effects on free fatty acid or glucagon concentrations.
In vitro insulin binding. Specific insulin binding to cultured rat hepatocytes was 7.2±0.3% of the added trace (n = 19) . No significant differences in specific binding were noted at any of the five ethanol concentrations (from 100 to 1,000 mg/dl) studied. This was true regardless of whether cell cultures were preincubated in the presence of ethanol or whether ethanol was added to the '25I-insulin-binding assay mixture. Scatchard analysis of competitive insulin binding in the presence of 200 mg/dl of ethanol showed no effect of ethanol on binding affinity or receptor number. There was also no effect of ethanol on tracer stability as evidence by TCA precipitability nor on hepatocyte viability as judged by trypan blue exclusion.
Discussion
The major findings in this study, namely the profound inhibitory effect of ethanol on the oxidation of other fuels, were obtained by indirect calorimetry. In order to use this technic in the presence of ethanol, it was necessary to demonstrate that all the ethanol, which had disappeared from the blood during the glucose infusion study (24±2.9 g) and was not excreted in urine or breath, nor remained in the body as acetate, had been completely oxidized to CO2 and water. This was accomplished in six subjects in whom '4C02 was collected quantitatively for 4 h after they received ethanol containing trace amounts of [1-'4C]ethanol followed by intravenous glucose (protocol 3). The results showed that virtually all the ethanol which was metabolized was oxidized to CO2 and water (Table I) . This allowed us to correct the respiratory quotients obtained by indirect calorimetry for the amounts of 02 consumed and CO2 generated from ethanol oxidation and to determine true CHO and fat oxidation rates.
To our knowledge, similar studies have not previously been performed in nonfasting human subjects. Bartlet and Barnet (27) After glucose infusion, ethanol oxidation continued unchanged, the already severely depressed fat oxidation decreased further, approaching 0 mg/min at 150 min, and the 249% rise in CHO oxidation seen in controls (at 120 min) was mostly abolished. Thus, ethanol appeared to act as a preferred fuel, almost totally replacing fat as substrate for oxidation during the basal period and preventing the large glucose load, which entered the intracellular space after intravenous glucose administration, from being oxidized. Our results are compatible with earlier work by others showing that ethanol inhibited oxidation ofFFA and ofalanine in rat liver (29) (30) (31) . They also support the proposition by others that the ethanol induced inhibition of fat oxidation may play a role in the fatty infiltration of the liver that accompanies prolonged alcohol intake (for review see Lieber [32] ). The cause for the preferred oxidation ofethanol was not investigated. It is known, however, that ethanol is quantitatively oxidized in the liver to acetate (33) . Acetate is a common product of the metabolism of CHO, fat, and some amino acids. It is readily activated to acetyl-coenzyme A and promptly oxidized in the citric acid cycle (34, 35) .
A quantitative assessment of the effect ofethanol on CHO, fat, and protein oxidation has not been reported previously. Indirect calorimetry has been used to examine this question during the early part of this century (36) (37) (38) . These investigators were unable to separate ethanol oxidation from the oxidation of other fuels and thus could not quantitate rates ofCHO, fat, and protein oxidation. Nevertheless, they observed a decrease in the respiratory quotient under the influence of ethanol which they interpreted as an indication that ethanol had replaced other substrates as fuel for oxidation.
In addition to its profound effects on fuel oxidation, ethanol also altered the rates at which glucose entered and disappeared from its extracellular space. During the basal period (0-60 min) ethanol depressed GR. by 30% (from 2.4±0.2 to glucose-glycogen-transferase in rat diaphragm (39) and to inhibit glycogen synthesis in rat liver (40 In conclusion, we have shown that under the conditions of this study, ethanol replaced fat as the predominant fuel for oxidation providing approximately two-thirds of basal caloric requirements. When an intravenous glucose load was given, ethanol prevented its oxidation. In addition, ethanol caused acute and comparable reductions in the rates of glucose appearance and disappearance. Ethanol did not alter glucose tolerance, because its diabetogenic effects on glucose disappearance and oxidation were counterbalanced by its potentiating action on glucose-stimulated insulin release and its reduction in hepatic glucose production (GRa). These data suggest, that in individuals with impaired insulin secretory reserve, the net effect of ethanol may be a deterioration of glucose tolerance and may occasionally result in overt diabetes.
